U.S. patent application number 15/720759 was filed with the patent office on 2018-05-03 for methods for rapidly transforming monocots.
The applicant listed for this patent is Monsanto Technology LLC. Invention is credited to Brenda Lowe, John Purcell, Jyoti R. Rout, Anne Spelletich, Michael Spencer, Melissa Way.
Application Number | 20180119157 15/720759 |
Document ID | / |
Family ID | 38779916 |
Filed Date | 2018-05-03 |
United States Patent
Application |
20180119157 |
Kind Code |
A1 |
Rout; Jyoti R. ; et
al. |
May 3, 2018 |
METHODS FOR RAPIDLY TRANSFORMING MONOCOTS
Abstract
The present invention provides methods for transforming monocot
plants via a simple and rapid protocol, to obtain regenerated
plants capable of being planted to soil in as little as 4-8 weeks.
Associated cell culture media and growth conditions are also
provided, as well as plants and plant parts obtained by the method.
Further, a method for screening recalcitrant plant genotypes for
transformability by the methods of the present invention is also
provided. Further, a system for expanding priority development
window for producing transgenic plants by the methods of the
present invention is also provided.
Inventors: |
Rout; Jyoti R.; (Portland,
OR) ; Lowe; Brenda; (Mystic, CT) ; Purcell;
John; (Mystic, CT) ; Spelletich; Anne;
(Pawcatuck, CT) ; Spencer; Michael; (Mystic,
CT) ; Way; Melissa; (Westerly, RI) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Monsanto Technology LLC |
St. Louis |
MO |
US |
|
|
Family ID: |
38779916 |
Appl. No.: |
15/720759 |
Filed: |
September 29, 2017 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
14483748 |
Sep 11, 2014 |
9783813 |
|
|
15720759 |
|
|
|
|
13791186 |
Mar 8, 2013 |
8853488 |
|
|
14483748 |
|
|
|
|
11848648 |
Aug 31, 2007 |
8395020 |
|
|
13791186 |
|
|
|
|
60841519 |
Aug 31, 2006 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
C12N 15/8265 20130101;
C12N 15/8201 20130101; C12N 15/8209 20130101; C12N 15/8212
20130101; C12N 15/821 20130101; C12N 15/8205 20130101 |
International
Class: |
C12N 15/82 20060101
C12N015/82 |
Claims
1.-38 (canceled)
39. A system for expanding a priority development window for
producing transgenic plants, comprising: a) selecting a candidate
DNA segment of interest for producing a transgenic plant based at
least in part on data collected in a first field test; b) preparing
a transgenic monocot plant comprising the candidate DNA segment by
the method of claim 1; and c) assaying the transgenic plant for a
desired phenotype and/or genotype in at least a second field test
conducted in a growing season subsequent to that in which the first
field test is conducted.
40. The method of claim 39, wherein one or both of the first field
test or second field test are conducted in the mid-west United
States.
41. The method of claim 39, wherein assaying the transgenic plant
comprises measuring agronomic performance.
42. The method of claim 39, wherein the second field test is a
hybrid yield test.
43. The method of claim 39, wherein the second field test is
performed two growing seasons after the first field test.
44. A method for screening cells of a crop plant line for
transformability, comprising a) culturing crop plant explants on a
growth medium that supports production of shoot primordia within
about 1-2 weeks; b) culturing the shoot primordia under conditions
that support shoot elongation for at least about a further week in
the dark to obtain growing shoot tissue and/or plantlets; c)
culturing the tissue or plantlets of step (b) on a plant growth
medium for at least about a further week to obtain shoot buds
and/or plants; wherein the transformability of the cells is
measured by the ability of shoot primordia to produce shoot buds
and/or plants following step (c).
45. The method of claim 44, wherein the growth medium of step (a)
comprises an effective ratio of cytokinin and auxin to support
production of shoot primordia.
46. The method of claim 45, wherein the ratio of cytokinin to auxin
in the growth medium of step (a) is from about 0.005 to about 0.03
(w/w).
47. The method of claim 46, wherein the growth medium of step (a)
is Lynx 1947.
48. The method of claim 44, wherein the growth medium of step (b)
comprises cytokinin.
49. The method of claim 48, wherein the growth medium of step (b)
is Lynx 2424.
Description
BACKGROUND OF THE INVENTION
[0001] This application claims the priority of U.S. provisional
application Ser. No. 60/841,519 filed Aug. 31, 2006, the entire
disclosure of which is incorporated herein by reference.
1, Field of the Invention
[0002] The invention generally relates to plant biotechnology. More
specifically, it relates to improved methods for transformation of
monocots with a gene of interest.
2, Description of the Related Art
[0003] Genomics-based approaches in plant biotechnology have
enabled identification and isolation of a large number of genes and
have necessitated the need for reliable and efficient
high-throughput transformation production systems for testing the
utility of these genes by transforming them into economically
important monocots such as corn. Agrobacterium-mediated
transformation of monocots such as corn, rice, and wheat is a
widely used experimental approach, often with the use of
meristematic tissue such as immature embryos as the explants of
choice (e.g. Ishida et al., 1996; Zhao et al., 2001; Frame et al.,
2002). For rice, transformation of imbibed seeds has also been
reported (Toki et al., 2006). To date, the most common methods
following the contacting of cells with Agrobacterium include:
culturing explant tissue such as immature embryos ("co-culture"),
possibly including a "delay" or "resting" (non-selective) step, and
followed by culture on selection medium containing auxin(s)
allowing de-differentiation of cells to form callus. During this
callusing phase, transformed resistant callus tissue is selected in
the presence of an appropriate selection agent on a selection
medium. This is followed by growth of cells under conditions that
promote differentiation of the callus and regeneration of the
callus into plants on regeneration and rooting media. This process
has typically required at least 10-12 weeks to produce plants that
can be transferred to soil for further growth. The process also
requires several manual transfers of tissue throughout the
transformation process and uses several different types of
media.
[0004] Thus use of standard transformation and regeneration
protocols is time consuming and inefficient, and negatively impacts
the transgenic, product development timeline, given that there is
usually a seasonally limited "priority development window" for
making decisions regarding which genetic constructs to prioritize
for use in larger scale transformation work based on results
obtained during initial research. There is therefore a need in the
art of monocot transformation to produce transgenic plants quickly
to provide more time and flexibility for making research and
product development decisions during a priority development window.
Such a high throughput system for corn transformation could produce
a large number of transgenic plants for testing genes and creating
useful plants while lowering material and labor costs.
[0005] Further, embryogenic culture responses of different breeding
lines differ greatly, limiting the genotypes of crops such as corn
that can be transformed. Accordingly, some lines can form
embryogenic callus readily, although many, in general, fail to form
any embryogenic callus. Such lines are often considered
"recalcitrant" lines. This can require use of non-elite lines for
transformation, which can require many generations of breeding to
produce agronomically-elite transgenic varieties. Thus there is
further a need for transformation methods that allow transformation
of hitherto "recalcitrant" corn genotypes to allow a wider choice
of transformable lines for product development, as well as for
screening such genotypes for their potential transformability.
SUMMARY OF THE INVENTION
[0006] In one aspect, the invention provides a method for producing
a transgenic monocot plant comprising: a) transforming an explant
with at least a first selected DNA; h) culturing the explant in a
first culture medium comprising an effective ratio of cytokinin and
auxin in order to promote development of regenerable structures
capable of root or shoot formation; and c) culturing the explant in
at least a second and/or third culture medium that supports the
simultaneous growth of root and shoot tissues, to produce a
regenerated transgenic monocot plant; wherein the regenerated
transformed monocot plant is produced within about 4-8 weeks of
transforming the explant. The method may further comprise, in one
embodiment, transferring the regenerated transgenic monocot plant
to a plant growth medium. In particular embodiments, the growth
medium is a non-sterile matrix, including a non-sterile matrix
comprised in a plug.
[0007] In certain embodiments, the regenerable structures are
formed within about 6-14 days of transforming the explant. In other
embodiments, step (b) is completed within about 6-14 days of
transforming the explant. In another embodiment, step (b) is
carried out for a length of from about 6 to about 12 days. In yet
other embodiments, steps (a) and (h) are carried out without
proliferating a callus for more than about 10 days to about two
weeks following transforming of the explant. In certain
embodiments, the first culture medium comprises a bactericidal
compound, such as carbenicillin or other compound that inhibits
growth of the Rhizobia, including Agrobacterium, used for
transforming the explant. In other embodiments, the second and/or
third culture medium comprises sucrose, at a concentration higher
than is found in the first culture medium. In particular
embodiments, the first culture medium comprises Lynx 1947.
[0008] In other embodiments, step (c) comprises culturing the
explant in an added plant growth regulator-free liquid culture
medium that supports the simultaneous growth of root and shoot
tissues, to produce a regenerated transgenic monocot plant, In
particular embodiments, the culture medium that supports the
simultaneous growth of root and shoot tissues comprises Lynx 2067.
In further embodiments, step (c) is begun within about 4-8 I weeks
of transforming the explant.
[0009] In certain embodiments, the ratio of cytokinin to auxin in
the first culture medium is from about 0.005 to about 0.03 (w/w).
In other embodiments the ratio of cytokinin to auxin in the first
culture medium is from about 0.005 to about 0.03 on a molar basis.
In particular embodiments the cytokinin may be selected from the
group consisting of BAP, zeatin, kinetin, and TDZ; and the auxin
may be selected from the group consisting of IAA, 2,4-D, NAA, IBA,
and dicamba. In other embodiments, the cytokinin and/or auxin in
the first culture medium may comprise a plant growth-regulatory
effect equivalent to these amounts and ratios of the above listed
cytokinins or auxins.
[0010] In yet other embodiments, step (c) further comprises
culturing the explant in a second culture medium comprising an
increased ratio of a shoot forming growth regulator to auxin
relative to the first medium to promote development of root(s) and
shoot(s) simultaneously. In particular embodiments the medium of
step (c) is Lynx 2068 and/or Lynx 2202.
[0011] Certain embodiments of the methods of the present invention
may further comprise culturing the explant in a second and/or third
culture medium lacking added plant growth regulators. In some
embodiments the ratio of shoot forming growth regulator to auxin in
the second medium is from about 0.02 to about 0.06 (w/w). In
particular embodiments, the second medium is Lynx 2202 or Lynx
2068. In certain embodiments, fresh growth medium is not added
subsequent to the start of step (c).
[0012] In yet other embodiments, the first culture medium comprises
about 0.001 mg/L, to about 10 mg/L of cytokinin and about 0.1 mg to
about 15 mg/L auxin, for instance about 0.005 mg/L cytokinin to
about 0.05 mg/L cytokinin, and about 0.1 mg/L auxin or 0.2 mg/L
auxin to about 0.5 mg/L auxin. In still further embodiments, the
explant is further cultured on a fourth medium between culturing on
the first and the second medium, wherein the fourth medium
comprises an effective amount of auxin and cytokinin to promote
callus proliferation. In particular embodiments, the fourth medium
is Lynx 2063.
[0013] In other embodiments, the explant is further cultured on a
fifth medium between culturing on the second and the third medium,
wherein the fifth medium comprises an amount of cytokinin effective
to promote shoot growth. In particular embodiments, the fifth
medium is Lynx 2066.
[0014] In certain embodiments, transforming the explant comprises
bacterially-mediated transformation. In particular embodiments,
bacterially mediated transformation is carried out using a
bacterium selected from the group consisting of Agrobacterium sp.,
Rhizobium sp., Sinorhizobium sp., Mesorhizobium sp., and
Bradyrhizobium sp.
[0015] In other embodiments, the second and/or third culture medium
comprises an amount of auxin that is reduced relative to the amount
in the first medium, cytokinin, abscisic acid, or a combination. In
a particular embodiment, the second and/or third culture medium
comprises less than half as much auxin or auxin-like plant growth
regulator activity as the first medium.
[0016] In certain embodiments, the first culture medium and culture
medium that supports the simultaneous growth of root and shoot
tissues are liquid media. In other embodiments, the first culture
medium is a semi-solid medium. In particular embodiments, each
medium used subsequent to the first culture medium is a liquid
medium. In certain embodiments, steps (b) and (c) are carried out
in a single container.
[0017] In certain embodiments, the monocot plant is a corn, rice,
sorghum, wheat, rye, millet, sugarcane, oat, triticale,
switchgrass, or turfgrass plant. In a particular embodiment, the
monocot is a corn plant.
[0018] In another aspect, the invention provides a system for
expanding a priority development window for producing transgenic
plants, comprising: (a) selecting a candidate DNA, segment of
interest for producing a transgenic plant based at least in part on
data collected in a first field test; (b) preparing a transgenic
monocot plant comprising the candidate DNA segment by the method of
claim 1; and (c) assaying the transgenic plant for a desired
phenotype and/or genotype in at least a second field test conducted
in a growing season subsequent to that in which the first field
test is conducted. In particular embodiments, one or both of the
first field test or second field test are conducted in the mid-west
United States. In certain embodiments, assaying the transgenic
plant comprises measuring agronomic performance. In particular
embodiments, the second field test is a hybrid yield test. In yet
other embodiments, the second field test is performed two growing
seasons after the first field test.
[0019] A further aspect of the present invention provides a method
for screening cells of a crop plant line for transformability,
comprising (a) culturing crop plant explants on a growth medium
that supports production of shoot primordia within about 1-2 weeks;
(b) culturing the shoot primordia under conditions that support
shoot elongation for at least about a further week in the dark to
obtain growing shoot tissue and/or plantlets; and (c) culturing the
tissue or plantlets of step (b) on a plant growth medium for at
least about a further week to obtain shoot buds and/or plants;
wherein the transformability of the cells is measured by the
ability of shoot primordia to produce shoot buds and/or plants
following step (c).
BRIEF DESCRIPTION OF THE FIGURES
[0020] FIG. 1. Line diagram of the control ("BPD") transformation
method and two illustrative embodiments of the present invention
showing number of culture steps and tissue transfer and media
transfer/change steps, One small block represent about one week
duration. Dark arrows represent physical transfer of explants to a
new container. Arrows with pattern represent aspiration and media
change. Arrows with stripes represent addition of media without
aspiration.
[0021] FIG. 2. The presence of cytokinin during the first medium
enables efficient and. rapid transformation by facilitating
production of shoot primordia. Explants were histochemically
assayed for gus expression 10 days post transformation and showed
large transgenic sectors (TS) and shoot primordium (SP).
[0022] FIG. 3. Four (A), six (B), and seven (C) weeks old
transgenic corn plants produced by the method of the present
invention.
[0023] FIG. 4. Line diagram showing further reduction in number of
culture steps, tissue transfer steps, and media transfer/change
steps. One small block represent about one week duration. Dark
arrows represent physical transfer of explants to a new container.
Arrows with pattern represent aspiration and media change. Arrows
with stripes represent addition of media without aspiration.
[0024] FIG. 5. Impact of Rapid Liquid Culture (RLC) protocol on
transformation initiation during the "priority development
window".
DETAILED DESCRIPTION OF THE INVENTION
[0025] The invention provides improved transformation methods that
substantially reduce the time required for production of transgenic
plants and expands the range of genotypes that can be transformed.
In one embodiment, use of liquid media combined with efficient
plant-handling procedures and simplified media and culture steps
offers advantages such as shorter production time, higher
through-put, lower material and labor costs, and ergonomic safety
benefits, while maintaining transformation frequency (TF) at a
useful level, or even improving TF.
[0026] Further, by allowing production of transformed corn plants
via such rapid methods, it is now possible to more efficiently use
a seasonally-affected priority development window, i.e. for making
decisions regarding transformation constructs and events in view of
planting seasons at various locations, as well as based on the
results of field tests conducted within those locations. These
locations include, for instance, the United States Corn Belt,
including all or most of Iowa, Indiana, Illinois, and Ohio, and
parts of South Dakota, Nebraska, Kansas, Minnesota, Wisconsin,
Michigan, Missouri, and Kentucky. This reduces barriers for
planning and prioritizing gene-construct and plant
transformation-event studies, Thus, shortening a corn
transformation protocol from 10-12 weeks to 6-7 weeks or less
effectively expands the product development window by 5-6 weeks,
allowing for up to twice the transformation capacity in a timeframe
such that yield testing of additional transformants initiated
during the priority development window is possible in the second
growing season subsequent to the occurrence of the transformation
event.
[0027] In certain aspects, the inventors found that the use of
liquid media with a matrix at various steps instead of the commonly
used semi-solid media may result in lower TF. However, use of
liquid selection and regeneration media with a delay medium
containing cytokinin resulted in similar TF as with semi-solid
selection and regeneration medium. Therefore, a faster method has
been developed by combining previously separate delay and
co-culture steps by use of one medium while maintaining/improving
the TF. The presence of cytokinin in co-culture and delay medium
(the first medium) triggers an early regeneration response while
reducing callusing or simultaneous callusing and plant
regeneration, thus leading to faster regeneration. The presence of
carbenicillin, a bactericidal compound in co-culture medium allows
explants to be cultured on the same medium for an extended period
i.e. 7-14 days after DNA delivery by Agrobacterium-mediated
transformation. Further, the traditional separate callus
proliferation and selection step(s) can be eliminated, while still
achieving an acceptable TF, as explants may be directly transferred
to a second and/or third medium that promotes shoot bud primordia
growth and development. Thus, importantly, previously
"recalcitrant" genotypes that have shown limited embryogenic
response and transformability via a callus-based approach may now
be directly used as transformation targets, and without further
physical manipulation of explant material i.e. sub-culturing with
manual transfer to different media, by use of culture regimes as
described herein.
[0028] The transformation methods described herein provide a
significant improvement over the current transformation method
known in the art. By using such methods, it was surprisingly found
that a transformed plant can be produced within 4-6 weeks after
contacting of cells with a transforming agent that is ready for
transplanting into a growth matrix such as plug and/or soil and is
produced by more efficient procedures and with a broader range of
genotypes. In some aspects, the methods also employ liquid medium
with a suitable support matrix. Use of the liquid culture reduces
the number of transfer steps from six to as few as two or three.
Still further, the step of selecting a transformed cell and
regeneration can be achieved in a single container until plants are
transferred to soil. The methods are thus suitable for a
high-throughput automated production system.
[0029] Certain monocot genotypes respond poorly to embryogenic
culture conditions. That is, embryos, or embryogenic callus leading
to efficient regeneration, are not produced under these conditions.
Such "recalcitrant" genotypes have transformation frequencies at or
near zero when previously described methods are attempted. Thus,
the current methods that can be used to transform a wide variety of
genotypes, especially recalcitrant lines, provide a wider choice of
transformable lines and represent a significant advance in the
art.
[0030] Further, methods for assessing the transformability of cells
of a monocot crop plant line have typically focused on measuring
the ability of a given line to produce embryogenic callus under the
right conditions. These conventional approaches for screening for
embryogenic callus formation utilize immature embryos that are
isolated and grown on tissue culture media capable of supporting
embryogenic callus formation. Just as important for
transformability is the ability of a cell line to sustain such
embryogenic callus growth over time, since some cell lines display
a brief burst of callus formation, but do not subsequently maintain
their embryogenic potential.
[0031] Thus, one embodiment of the present invention comprises a
novel method to screen crop plant cells for transformability. This
method, in one aspect, comprises culturing explants (e.g. maize
immature embryos) on a medium capable of producing shoot primordia
in a short time (e.g. within 1-2 weeks, for instance within 1
week). The tissues are then transferred to a
regeneration/elongation medium for about 2-3 weeks under dark
conditions, before being placed on a growth medium for about 2-3
additional weeks. The ability of lines to regenerate shoot buds
and/or plants under these conditions indicates their transformation
competence by the methods of the present invention, including those
in which no callus growth phase is provided, or in which a period
of callus growth is substantially reduced from previous cell
culture regeneration methods.
[0032] A method of the invention in one embodiment also includes
exposing a. transformable explant to a transforming agent. Suitable
explants include transformable plant parts such as callus, cells
and embryos. In specific embodiments the explant may be an immature
embryo of about 1.0-3.0 mm in length, for instance the embryo size
may be between about 1.6-2.6 mm in length, about 8-14 days post
pollination (DAP), including an embryo size of about 2.0 mm at
about 10-12 days post pollination. The stages of corn embryo
development and morphology have been described (e.g. Matthys-Rochon
et al., 1998, and references therein). Suitable transforming agents
include plant transforming bacteria carrying a DNA construct to be
transferred. Examples of such bacteria include Agrobacterium sp.,
Rhizobium sp., Sinorhizobium sp., Mesorhizobium sp., and
Bradyrhizobium sp. (e.g. Broothaerts et al., 2005; U.S. patent
application Ser. No. 11/749,583). The explant can also be exposed
to the DNA construct via direct uptake, microinjection,
electroporation, and micro-projectile bombardment, or by any other
method known to those skilled in the art.
[0033] Typically, a DNA construct includes one or more expression
units. These expression units generally comprise in 5' to 3'
direction: a promoter, nucleic acid encoding for a useful trait or
for gene suppression, a 3' untranslated region. Several other
expression elements such as 5' UTRs, organellar transit peptide
sequences, and introns (especially for monocots) are usually added
to facilitate expression of the trait. Other genetic components
that serve to enhance expression or affect the transcription or
translation of a gene in a plant are also envisioned for use.
[0034] Numerous plant promoters are known to those of skill in the
art. Such promoters include but are not limited to the nopaline
synthase (NOS) promoter, cauliflower mosaic virus (CaMV) 19S and
35S promoters (e.g. see U.S. Pat. No. 5,352,605), the enhanced CaMV
35S promoter (e355), a ssRUBISCO promoter, and an actin promoter
(e.g. rice actin promoter; see U.S. Pat. No. 5,641,876), among
others. The DNA construct may include a second expression unit
wherein the nucleic acid encodes a maker protein for selecting,
screening, or scoring a transformed cell.
[0035] For the practice of the present invention, compositions and
methods for preparing and using constructs and host cells are well
known to one skilled in the art, see for example, Sambrook, et al.
(2000). Methods for making transformation constructs particularly
suited to plant transformation include, without limitation, those
described in U.S. Pat. Nos. 4,971,908, 4,940,835, 4,769,061 and
4,757,011, all of which are herein incorporated by reference in
their entirety.
[0036] Normally, the expression units are provided between one or
more T-DNA borders on a transformation construct. The
transformation constructs permit the integration of the expression
unit between the T-DNA borders into the genome of a plant cell. The
constructs may also contain the plasmid backbone DNA segments that
provide replication function and antibiotic selection in bacterial
cells, for example, an Escherichia coli origin of replication such
as ori322, a broad host range origin of replication such as oriV or
oriRi, and a coding region for a selectable marker such as
Spec/Strp that encodes for Tn7 aminoglycoside adenyltransferase
(aadA) conferring resistance to spectinomycin or streptomycin, or a
gentamicin (Gm, Gent) selectable marker gene. For plant
transformation, the host bacterial strain is often Agrobacterium
tumefaciens ABI, C58, LBA4404, EHA101, or EHA105 carrying a plasmid
having a transfer function for the expression unit. Other strains
known to those skilled in the art of plant transformation can
function in the present invention.
[0037] After contacting an explant with a transforming agent, the
explant may be cultured on a first medium (e.g. Lynx #1947) that
combines the attributes of a co-culture and a delay medium due to
the presence of a bactericidal compound such as Carbenicillin. Such
a medium comprises a cytokinin and an auxin. By providing an
effective amount of plant growth regulators and appropriate ratio
of cytokinin to auxin or any other growth regulators that are known
to affect callusing and/or shoot bud formation, such a medium
allows subsequent regeneration of tissues, including transformed
tissues, to begin without requiring a separate callus proliferation
phase or a sustained embryogenic response. The effective growth
regulator(s) concentrations and/or ratio of cytokinin to auxin
could vary from genotype to genotype and the type of plant species
used. Subsequent to the first medium, in certain embodiments the
explant may be cultured on a growth regulator free medium to
promote plant regeneration. In certain embodiments this medium is a
liquid medium.
[0038] The methods provided by the invention may be carried out
using genotypes that are capable of producing a classical
embryogenic callus response, as well as for recalcitrant genotypes
that fail to show appreciable amount of embryogenic culture
response, or sustained culture response, with other previously
known culture methods. The culture period on the first medium may
be varied depending upon the need for a particular TF. In one
embodiment, the culture period on the first medium is from about 6
or 7 to about 10-14 days. Earlier regeneration also reduces the
number of clonal (i.e. sister) plants, including non-transformed
plants, that tend to arise following callusing and that may make
downstream screening less efficient. The cytokinin may be added to
the inoculation or co-culture medium. Alternatively, the cytokinin
may be produced by a cytokinin synthesis gene such as a gene for
isopentenyl transferase (e.g. U.S. Pat. No. 6,294,714) within the
explant of a transformed line.
[0039] Examples of various cytokinins that are suitable for use
either alone or in combination with the present method include
6-Benzyl aminopurine (BAP), kinetin, zeatin, adenosine phosphate,
thidiazuron (TDZ) and other cytokinin like compounds. Examples of
various auxins that are suitable for use either alone or in
combination with the present method include IAA, 2,4-D, NAA, IBA,
dicamba, and other auxin like compounds. One of skill in the art of
plant cell culture and transformation would be able to determine
appropriate levels of shoot forming plant growth regulators and
auxins, and appropriate ratios of the two, that are suitable for
use with the present invention. For instance, levels of these or
other plant growth regulators with a functionally equivalent level
of activity as, for instance, BAP and/or 2,4 D in corn or in
another crop plant, may be determined by varying the levels of such
growth regulators present in growth media while explants are grown
in the media, and following the growth of the explants and tissues
derived therefrom. Thus, if other plant growth regulators are used,
they would nevertheless comprise a plant growth-regulatory effect
equivalent to these contemplated amounts and ratios of the above
listed cytokinins or auxins.
[0040] A dedifferentiated explant comprising at least one shoot
primordium can be produced after co-culture/delay on the first
medium and may be cultured on a second medium including an
increased ratio of a shoot forming growth regulator, such as a
cytokinin or ABA, to auxin than the first medium. Alternatively,
the second and/or third medium may comprise a reduced amount of
auxin than the first medium, and may further comprise an effective
amount of sucrose higher than the first medium for reducing
proliferation of callus and faster regeneration. For instance, 50
g/L, sucrose in the second medium and 60 g/L, in the third medium
may be utilized. In another alternative, the second medium and/or
third medium may comprise an effective amount of a shoot forming
growth regulator such as a cytokinin and/or ABA only, with no added
auxin or auxin-like activity. Subsequently, the explant may be
cultured on a third culture medium comprising little or no plant
growth regulators for shoot elongation and root production.
[0041] In one embodiment, the method combines the traditional
co-culture and delay medium into a first medium thereby reducing
the number of media required for transformation and subsequent
culture from five to four. In another embodiment, the method
eliminates the callus proliferation/selection medium, two
regeneration medium, one rooting medium and provides modified
regeneration/elongation media that may lack appreciable amounts of
added plant growth regulator, thereby reducing the number of media
required for transformation from six to three. In yet another
embodiment, the method uses only the first medium and the third
medium thereby reducing the number of media required for
transformation from six to two.
[0042] In other embodiments, the first medium is a semi-solid
medium and the other media are liquid media. In yet another
embodiment, all media used are liquid media. However, it will be
apparent to those skilled in the art to use a combination of
semi-solid or liquid media and to use only one or more of the
modifications provided herein, depending upon their need.
[0043] In a specific embodiment, the explant is cultured on the
first culture medium, such as Lynx #1947, for about 7-14 days, on
the second culture medium, such as Lynx #2202, for about 7 days,
and on the third culture medium, such as Lynx #2067, for about
14-28 days. However, the number of days on one or more media can be
increased or decreased by visual inspection of the growth of the
transgenic plant by those skilled in the art. In another
embodiment, the explant is additionally cultured on a fourth medium
between the first and the medium for about 14 days and on a fifth
culture medium for about 7 days between the and the third culture
medium. The fourth medium, such as Lynx #2063, can contain plant
growth regulators including auxin, cytokinin, and AgNO.sub.3, and
is formulated to support callus proliferation. The fifth medium,
such as Lynx #2066, can contain cytokinin but generally no auxin,
and is formulated to support shoot growth and elongation. In
certain embodiments, the added second, third, fourth, and/or fifth
media may comprise no effective amount of a plant growth regulator,
while promoting the development of regenerated plants. The second
or other subsequent media may be liquid, semi-solid, or solid
media. In particular embodiments, only two media may be employed,
i.e. a co-culture/delay medium such as, for instance, Lynx 1947,
and a subsequent medium, for instance derivatives of Lynx 2067 and
Lynx 2066 (also described as "third" and "fifth medium"
respectively), lacking appreciable amounts of an auxin, in a method
to obtain transformed regenerated plants within 4-8 weeks of
transformation (For media compositions see e.g. Tables 2, 3).
[0044] The number of days on one or more media can be increased or
decreased by visual inspection of the explants by those skilled in
the art. The invention thus provides a regenerated plant, and parts
thereof, that is capable of growth in a soil-based medium or any
other non-sterile matrix within 4-6 weeks after the explant from
which it is derived was contacted by a transforming agent, such as
by transforming an explant with a selected DNA. In a particular
embodiment, 4-8 weeks old regenerated plants are transplanted into
plugs (Q Plugs by International Horticultural Technologies,
Hollister, Calif.) for further growth and development and initial
screening, for instance to determine their genotype and/or
phenotype with respect to a transgene of interest.
[0045] In other embodiments, the second, third, fourth, and/or
fifth media also include a selection agent such as the herbicide
glyphosate for terminating or at least retarding growth of most of
the cells, tissue, or organ into which the DNA construct has not
been delivered. Other suitable selection agents that may be used
alone or in combination, include, but are not limited to auxin-like
herbicides such as dicamba or 2,4-D, MCPA, 2,4-DB, glufosinate,
acetolactate synthase inhibitors, protoporphyrinogen oxidase
inhibitors, and hydroxyphenyl-pyruvate-dioxygenase inhibitors,
neomycin, kanamycin, paramomycin, G418, aminoglycosides,
spectinomycin, streptomycin, hygromycin B, bleomycin, phleomycin,
sulfonamides, streptothricin, chloramphenicol, methotrexate,
2-deoxyglucose, betaine aldehyde, S-aminoethyl L-cysteine,
4-methyltryptophan, D-xylose, D-mannose,
benzyladenine-N-3-glucuronidase. Examples of genes providing
tolerance to such selection agents are disclosed in Mild and
McHugh, (2004).
[0046] A variety of plant tissue culture media are known that, when
supplemented appropriately, support plant tissue growth and
development. These tissue culture media can either be purchased as
a commercial preparation or custom prepared and modified by those
of skill in the art. Reagents are commercially available and can be
purchased from a number of suppliers (see, for example, Sigma
Chemical Co., St. Louis, Mo.; and PhytoTechnology Laboratories,
Shawnee Mission, Kans.). Examples of such media include, but are
not limited to, those described by Murashige and Skoog (1962); Chu
et al. (1975); Linsmaier and Skoog (1965); Uchimiya and Murashige
(1962); Gamborg el at. (1968); Duncan et al. (1985); McCown and
Lloyd (1981); Nitsch and Nitsch (1969); and Schenk and Hildebrandt
(1972), or derivations of these media supplemented accordingly.
Those of skill in the art are aware that media and media
supplements such as nutrients and growth regulators for use in
transformation and regeneration are usually optimized for the
particular target crop or variety of interest. One may also select
various components such as basal salts, vitamins, carbon source
from one or the other medium to obtain desired growth and
development. Plant growth media used in a prior method (e.g. Cai et
al.; U.S. Patent Application Publication 20040244075, and
incorporated herein by reference) are shown in Table 1. Preferred
media compositions used in the present methods are listed in Tables
2 and 3. Differences between the recipes used in the present
invention and the standard recipes used in the conventional methods
of monocot transformation are, for instance, that conventional
methods use medium that allows callus proliferation and selection,
followed by regeneration and growth of the transgenic event. In
contrast, the media of the present invention allow just enough
callus formation for formation of shoot primordia thereby avoiding
chimeric plant formation and allowing efficient selection through
simultaneous callus formation and plant regeneration, in a manner
to allow high-frequency transformation.
[0047] In general, a 1.sup.st medium may function as a co-culture
and delay medium, and comprises plant growth regulators such as an
auxin (e.g. 2,4-D), a cytokinin (e.g. BAP), and silver nitrate, as
well as acetosyringone to facilitate Agrobacterium-mediated
transformation. The 1.sup.st medium may also contain a bactericidal
compound such as carbenicillin which allows explants to be cultured
on the same medium for an extended period i.e., 7-14 days after
contacting the explant with a transforming agent. A 2.sup.nd medium
(e.g. 2202) may also comprise such plant growth regulators, but
auxin is reduced. Importantly, this 2.sup.nd medium may function as
a regeneration medium. A 3.sup.rd medium (e.g. 2067) lacks growth
regulators, and functions as a regeneration or shoot elongation
medium. A 4.sup.th medium (e.g. 2063) comprises a similar amount of
growth regulators as the 1.sup.st medium, and may function to
support callus proliferation. A low level of a selective agent may
also be present, to favor growth of transformed tissue. A 5.sup.th
medium (e.g. 2066) lacks auxin and silver nitrate, and has a low
level of cytokinin, and supports regeneration. Alternatively, media
added subsequently to the 1.sup.st medium may comprise no effective
amount of a plant growth regulator, while supporting development
and growth of a regenerated plant. In a particular embodiment, a
different 2.sup.nd medium with no auxin but some cytokinin (e.g.
2347, 2348, 2415, 2414; see Table 3) may also be employed as the
regeneration medium which can support regeneration and elongation
in place of the initially described 2.sup.nd medium (i.e. 2202).
Media 2348, 2415, 2414 are essentially the same as 2066 but with
silver nitrate, and contain differing amounts of glyphosate. Medium
2347 is essentially the same as 2067, but with silver nitrate and a
cytokinin. Modifications of such media may be made by one of skill
in the art of plant cell transformation and tissue culture,
depending on the species and genotype of the subject explant
tissue, while maintaining the described cell culture
attributes.
TABLE-US-00001 TABLE 1 Media compositions used in a previous method
(Cai et al.; U.S. Patent Applic. Publn. 2004/00244075). 1278 1073
1071 (MSW (MS/6BA) (MSOD) Media Components/L 1233 50 + BAP),
(1.sup.st (2.sup.nd 1084 (Suppliers) (co-culture) (selection)
regeneration) regeneration) (rooting) MS Basal Salts 2.165 g 4.33 g
4.33 g 4.33 g 2.165 g (Phytotech) MS Vitamins (100X) 10 mL 10 mL 0
0 0 (Phytotech) MS Fromm Vitamins 0 0 1 mL 1 mL 0 (1000X)* BAP
(Sigma) 0 0.01 mg 3.5 mg 0 0 Thiamine HCL (Sigma) 0.5 mg 0.5 mg 0 0
0 2,4-D (Phytotech) 3 mg 0.5 mg 0 0 0 NAA (Sigma) 0 0 0 0 0.5 mg
IBA (Sigma) 0 0 0 0 0.75 mg Sucrose (Phytotech) 20 g 30 g 30 g 0 20
g Glucose (Phytotech) 10 g 0 0 10 g 0 Maltose (Phytotech) 0 0 0 20
g 0 Proline (Sigma) 115 mg 1.38 g 1.38 g 0 0 Casamino Acids 0 0.5 g
0.05 g 0.5 0 (Difco) Asparagine 0 0 0 0.15 0 monohydrate (Sigma)
Myo-inositol (Sigma) 0 0 0 0.1 g 0 Low EEO Agarose 5.5 g 0 0 0 0
(Sigma) Phytagel (Sigma) 0 3 g 3 g 3 g 3 g Acetosyringone 200 uM 0
0 0 0 (Aldrich) Carbenicillin 500 mg 500 mg 250 mg 250 mg 0
(Phytotech) Glyphosate (Gateway 0 0.1 mM 0.1 mM 0.1 mM 0.1 mM
Chemical) Silver Nitrate (Sigma) 3.4 mg 3.4 mg 0 0 0 pH 5.2 5.8 5.8
5.8 5.8 *Comprising 1250 mg/L nicotinic acid (Sigma), 250 mg/L
pyridoxine HCl (Sigma), 250 mg/L thiamine HCl (Sigma), and 250 mg/L
calcium pantothenate (Sigma).
TABLE-US-00002 TABLE 2 Media compositions used in various aspects
of the present invention. Media Components/L 1947 2063 2202 2066
2067 (Suppliers) 1898 2232 2233 (1.sup.st) (4.sup.th) (2.sup.nd)
(5.sup.th) (3.sup.rd) 2068 MS Basal Salts 4.33 g 4.33 g 4.33 g 4.33
g 4.33 g 4.33 g 4.33 g 4.33 g 4.33 g (Phytotech) MS Vitamins 10 mL
10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL 10 mL (100X) (Phytotech)
Thiamine HCL 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0.5 mg 0 0.5
mg (Sigma) 2,4-D (Phytotech) 0.5 mg 0.2 mg 0.2 mg 0.5 mg 0.5 mg 0.2
mg 0 0 0.2 mg Sucrose (Phytotech) 30 g 30 g 30 g 30 g 30 g 50 g 50
g 60 g 50 g Proline (Sigma) 1.38 g 1.38 g 1.38 g 1.38 g 1.38 g 0 0
0 0 Casamino Acids 0.5 g 0.5 g 0.5 g 0.5 g 0.5 g 0.5 g 0.5 g 0 0.5
g (Difco) ph 5.8 5.8 5.8 5.8 5.8 5.8 5.8 5.8 5.8 Low EEO Agarose
5.5 g 5.5 g 5.5 g 5.5 g 0 0 0 0 0 (Sigma) Post autoclave additives
Post filter sterilization additives Carbenicillin 50 mg 50 mg 50 mg
50 mg 500 mg 500 mg 500 mg 500 mg 500 mg (Phytotech) Acetosyringone
200 uM 200 uM 200 uM 200 uM 0 0 0 0 0 (Aldrich) BAP (Sigma) 0 0.01
mg 0 0.01 mg 0.01 mg 0.01 mg 0.01 mg 0 0.01 mg Glyphosate 0 0 0 0
0.2 mM 0.2 mM 0.1 mM 0.02 mM 0.2 mM (Gateway Chemical) Silver
Nitrate 3.4 mg 3.4 mg 3.4 mg 3.4 mg 3.4 mg 3.4 mg 0 0 0 (Sigma)
TABLE-US-00003 TABLE 3 Examples of other types of 2.sup.nd medium
used in the present invention. Media Components/L (Suppliers) 2347
2348 2414 2415 MS Basal Salts (Phytotech) 4.33 g 4.33 g 4.33 g 4.33
g MS Vitamins (100X) (Phytotech) 10 mL 10 mL 10 mL 10 mL Thiamine
HCL (Sigma) 0 0.5 mg 0.5 mg 0.5 mg Sucrose (Phytotech) 60 g 50 g 50
g 50 g Casamino Acids (Difco) 0 0.5 g 0.5 g 0.5 g pH 5.8 5.8 5.8
5.8 Post filter sterilization additives Carbenicillin (Phytotech)
500 mg 500 mg 500 mg 500 mg BAP (Sigma) 0.01 mg 0.01 mg 0.01 mg
0.01 mg Glyphosate (Gateway Chemical) 0.02 mM 0.2 mM 0.05 mM 0.1 mM
Silver Nitrate (Sigma) 3.4 mg 3.4 mg 3.4 mg 3.4 mg
[0048] To confirm the presence of the DNA construct in the
regenerated plant, a variety of assays can be performed. Such
assays include, for example, "molecular biological" assays, such as
Southern and northern blotting and PCR.TM.; "biochemical" assays,
such as detecting the presence of a protein product, e.g., by
immunological means (EUSAs and western blots) or by enzymatic
function: plant part assays, such as leaf or root assays: and also,
by analyzing the phenotype of the whole regenerated plant.
[0049] Once a gene has been introduced into a plant using the
present method, that gene can be introduced into any other plant
sexually compatible with the first plant by crossing, without the
need for directly transforming the second plant. Therefore, as used
herein the term "progeny" denotes the offspring of any generation
of a parent plant prepared in accordance with the present
invention. A "transgenic plant" may thus be of any generation.
[0050] The present invention also provides a plant and plant parts
produced by the method. Preferably, the plant is a monocot plant.
More preferably, the monocot plant is a crop plant selected from
the group consisting of: corn, rice, sorghum, wheat, rye, millet,
sugarcane, oat, triticale, turfgrass, and switchgrass plants. In a
particular embodiment the monocot plant is a corn plant. The plant
parts include, without limitation, seed, endosperm, ovule, pollen,
leaf, stem, and root. In a particular embodiment, the plant part is
a seed. The invention also includes and provides transformed plant
cells and tissues produced by the method.
[0051] The following examples illustrate the development of this
method.
EXAMPLES
[0052] The following examples are included to illustrate
embodiments of the invention. It should be appreciated by those of
skill in the art that the techniques disclosed in the examples that
follow represent techniques discovered by the inventor to function
well in the practice of the invention. However, those of skill in
the art should, in light of the present disclosure, appreciate that
many changes can be made in the specific embodiments which are
disclosed and still obtain a like or similar result without
departing from the concept, spirit and scope of the invention. More
specifically, it will be apparent that certain agents which are
both chemically and physiologically related may be substituted for
the agents described herein while the same or similar results would
be achieved. All such similar substitutes and modifications
apparent to those skilled in the art are deemed to be within the
spirit, scope and concept of the invention as defined by the
appended claims.
Example 1
[0053] Nucleic Acid Constructs and Transformation Agents
[0054] This example describes the making of the DNA constructs and
transformation of the DNA constructs into ABI Agrobacterium strain
(a disarmed C58 strain) used for transformation of corn immature
embryos. The plasmid pMON 97367 contains a cp4 gene as the
selectable marker and a gus gene as the screenable marker driven by
the chimeric rice actin and rice actin promoter, respectively.
Strains of Agrobacterium were prepared for transformation
essentially according to procedures described elsewhere, such as
Cai et al. (U.S. Patent Applic. Publn. 2004/00244075).
Example 2
[0055] Improving Throughput of Transformation
[0056] This example describes the development of a revised method
using liquid media during callus proliferation, selection, and
during regeneration steps in order to develop a simplified high
throughput method needing less tissue handing and which is
automatable. FIG. 1 shows an experimental design for this 8 week
liquid culture protocol ("Liquid Plug"--FIG. 1, middle diagram).
Table 4 shows the results when compared with the method,
essentially, of Cai et al (U.S. 2004/0244075, i.e. FIG. 1, top
diagram). The revised method is also modified from that found in
Example 3, in that explants were transferred to a fourth medium
(Lynx 2063) after the first medium for one to two weeks at
30.degree. C. in dark, transferred to a modified 2.sup.nd medium
(e.g. 2068; i.e. 2202 with added AgNO.sub.3), and then transferred
to a fifth medium (e.g. Lynx 2066) after the second medium for one
week at 27.degree. C. in dark.
[0057] As noted above, certain corn transformation methods are
described in the US Patent Application Publication 2004/0244075
(Cai et al.), and various media composition used are also described
therein. Table 4 shows that transgenic plants could be produced
within 8 weeks by making modifications to the method of Cai et al.,
including culturing on the 1.sup.st culture medium for an extended
period, reducing the culture time spent on the 4.sup.th culture
medium, reducing the culture time spent on 5.sup.th culture medium,
and reducing the culture time spent on the rooting medium used in
the current method (Table 1). Additionally, the 1.sup.st, 2.sup.nd,
3.sup.rd , 5.sup.th media were modified (see Table 1 and 2) by
adding cytokinin and reducing auxin, by substantially reducing
cytokinin and adding a small amount of auxin and increasing sucrose
amount, by removing all growth regulators and increasing sucrose,
and adding a small amount of cytokinin and auxin and increasing
sucrose, respectively. For example, Lynx 1233 used in a
conventional method described in Cai et al. does not support
prolonged growth and development of explant nor does it support
shoot primordia formation like the 1.sup.st medium (Lynx 1947) of
the current invention. Lynx 1278 of Cai et al. have similar
functions as Lynx 2063 of the current invention. The major
difference between the two systems is in the area of regeneration.
Plant regeneration by the method of Cai et al. uses a high
cytokinin pulse step (Lynx 1073), followed by shoot elongation
(Lynx 1071) and finally rooting of plantlets accompanied by further
growth and development on Lynx 1084. In contrast, regeneration by
the current method is achieved by simultaneous development of shoot
and root by an auxin step-down approach (Lynx 2068 and Lynx 2066).
Final growth and development of the plantlets are achieved on a
growth regulator free medium, Lynx 2067.
TABLE-US-00004 TABLE 4 Production of transgenic plants within 8
weeks using a liquid media culture method. % TF is the mean of at
least 3 independent experiments and is based on % of independent
transgenic plant events. # of explants to selection # Events
Treatment medium Produced TF (%) Control method 150 55 36.7 Liquid
media method 210 125 59.5
Example 3
[0058] Transformation Method
[0059] This example describes a transformation method, including
regeneration steps (FIG. 1, "Rapid Transformation" scheme, bottom
diagram), by which is obtained, after about as little as 6 weeks of
growth, a regenerated plant in a solid growth medium (e.g. growth
plug). In general, immature embryos (IEs) were excised manually or
via a fluid jet apparatus such as disclosed in U.S. Pat. No.
7,150,993, or US Patent Application Publn. No. 2005/0246786, and
inoculated with the Agrobacterium cells containing the DNA
construct of interest. The inoculated embryos were cultured on the
first medium (Lynx 1947) for about 7 (optionally to about 14) days
at 23.degree. C. for 1 day and at 30.degree. C. for the rest of the
time in dark, after which explants were transferred to a Petri
plate containing a support such as felt and/or filter paper (e.g.
Ahlstrom grade 610, 8.22 cm; Ahlstrom Corp., Helsinki, Finland) and
10 ml of a second medium (Lynx 2202), and the plates were incubated
at 30.degree. C. under dark conditions for about 1 week. After one
week in the presence of the second medium, the old medium was
aspirated off and 10 ml of the third medium (Lynx 2067) was added
and the plates were incubated at 30.degree. C. in dark for one more
week. At approximate one week intervals after the initial transfer
to the third medium, old medium was aspirated off and about 15-30
ml of the third medium was added again and plates were incubated at
27-30.degree. C. in 16/8 light-dark. After the 6.sup.th week
post-transformation, plants were transferred to plugs containing a
solid growth medium, under non-sterile conditions for hardening and
then to pots for further growth and development within the next 2
weeks. The media compositions used are shown in Table 2.
Example 4
[0060] Use of Cytokinin Facilitates Rapid Production of Shoots and
Plants
[0061] This example illustrates the use of cytokinin for initiating
early shoot primordia formation for faster production of transgenic
plants. Experiments were performed with or without BAP in the first
medium (see Table 2 for components) and the results are shown in
Table 5. FIG. 2 shows the production of shoot primordia on the
first medium. The results also show significant improvement in
transformation frequency when the cytokinin was used during this
step of the transformation process.
TABLE-US-00005 TABLE 5 Use of a cytokinin during the first step of
transformation process enhances transformation frequency due to
early shoot primordia formation. % TF is average of 4 experiments
and is based on % of independent transgenic plant events. Treatment
# of embryos Total # Events % TF (1 week) to selection Produced
Mean .+-. SD Lynx 1898; No BAP 315 41 13.0 .+-. 7.4 Lynx 1947; BAP
365 179 49.0 .+-. 2.3
Example 5
[0062] Simplification of Methods by Decreasing Callus Proliferation
and Selection Period
[0063] This example demonstrates production of transgenic plants
within 7 and 6 weeks by decreasing the time spent on Lynx 2063 by 1
week and thus limiting callus proliferation. The outline of the
experiment and results are shown in Table 6. The results suggest
that a reduced callusing phase can be used without affecting TF.
The results also suggested that a further reduction or elimination
in callusing phase may be possible which may speed-up the process
of transgenic plant production.
TABLE-US-00006 TABLE 6 Production of transgenic plants within 7 or
6 weeks by reducing the callusing phase. % TF is the mean of at
least 3 independent experiments and is based on % independent
transgenic plant events. STEPS Treatment 1 Treatment 2 Treatment 3
Co-culture and Lynx 1947 Lynx 1947 Lynx 1947 Delay; 8-10 days 1st
transfer; 1 wk Lynx 2063 Lynx 2063 Lynx 2063 2nd transfer, 1 wk
Lynx 2063 Lynx 2068 Lynx 2068 3rd transfer, 1 wk Lynx 2068 Lynx
2066 Lynx 2067 4th transfer, 1 wk Lynx 2066 Lynx 2067 Lynx 2067 5th
transfer, 2 wks Lynx 2067 Lynx 2067 plug (6 wks) 6th transfer, 1 wk
Lynx 2067 plug (7 wks) N/A 7th transfer plug (8 wks) N/A N/A TE
(Mean .+-. SD) 16.9 .+-. 1.0 26.0 .+-. 10.9 22.0 .+-. 5.9
Example 6
[0064] Development of Six Week Transformation Protocol by
Eliminating Callus Proliferation During Selection
[0065] This example demonstrates the production of transgenic
plants within 6 weeks by eliminating the callus proliferation and
selection step (Lynx 2063, 4.sup.th medium) and one of the
regeneration steps, on the fifth medium, completely. The
experimental design and the results are shown in Table 7. This
experiment included an already shortened method (treatment 1) with
one week callus proliferation/selection step on the fourth medium
and compared it with a method including direct regeneration on the
second medium that contained a lower 2, 4-D level than the first
medium. Thus in addition to reducing auxin level, an increased
ratio of shoot forming growth regulator to auxin is also
contemplated. This example demonstrates that the need for callus
growth and proliferation step during selection (the fourth and the
fifth media e.g. 2063 and 2066 media) can be eliminated and is
crucial to obtain transgenic events in a reduced amount of
time.
TABLE-US-00007 TABLE 7 Production of Transgenic Plants by
Eliminating the Callus Proliferation Step. % TF is the mean of at
least 3 independent experiments and is based on % independent
transgenic plant events. STEPS Treatment 1 Treatment 2 Co-culture
and Delay; 8- Lynx 1947 Lynx 1947 10 days 1st transfer, 1 wk Lynx
2063 Lynx 2202 2nd transfer, 1 wk Lynx 2068 Lynx 2068 3rd transfer,
1 wk Lynx 2066 Lynx 2067 4th transfer, 1 wk Lynx 2067 Lynx 2067 5th
transfer, 2 wks Lynx 2067 Lynx 2067 6th transfer, 1 wk Lynx 2067
Plug 7th transfer Plug TF (Mean .+-. SD) 18.8 .+-. 9.4 40.9 .+-.
18.7
Example 7
[0066] Some Callus Proliferation During Co-culture and Delay is
Required for Enhanced TF
[0067] This example illustrates the role of appropriate cell
proliferation of explants during co-culture and delay medium (the
first medium) on TF. The callus growth of the explants was
controlled by the level of 2,4-D in the co-culture/delay medium. As
shown in Table 8 the effect of one week culture on the 1st medium
(e.g., 2232, 1947, 2233 or 1898; Table 2) was tested, followed by a
six week transformation protocol. It is evident from the results
that amount of callusing during co-culture/delay before
regeneration determines TF. An auxin level at a lower concentration
i.e. 0.2 mg/L in Lynx 2232 had zero TF while explants cultured on
1947 having 0.5 mg/L gave a TF of about 35%. The results suggest
that some callus proliferation before growth on 2.sup.nd medium
(including regeneration) is necessary to allow for later shoot bud
formation. The amount of callus formation may be optimized by
varying the tissue culture parameters including, among others,
media components and duration of growth.
TABLE-US-00008 TABLE 8 Optimum callus phase during co-culture and
delay impacts TF. % TF is the mean of at least 3 independent
experiments and is based on % of independent transgenic plant
events. STEPS Treatment 1 Treatment 2 Treatment 3 Treatment 4
Co-culture and Lynx 2232 Lynx 1947 Lynx 2233 Lynx 1898 Delay; 1 wk
(7- 10 days) 1st transfer; 1 wk Lynx 2202 Lynx 2202 Lynx 2202 Lynx
2202 2nd transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 Lynx 2067 3rd
transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 Lynx 2067 4th
transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 Lynx 2067 5th
transfer, 1 wk Plug Plug Plug Plug TF 0 35.4 0.7 6.1
Example 8
[0068] Further Simplifications to Protocol
[0069] This example illustrates reducing the duration of growth of
explants on regeneration medium (2202) for further simplifying the
methods while still allowing obtention of plants within 6 weeks
while having no adverse effect on TF. In this study shown in Table
9, the effect of one week each on the second medium (2202; 2068)
(treatment 1) was compared with only one week on the second medium
2202 (treatment 2 and 3) followed by elongation on the third medium
(2067). The second medium 2202 is identical to 2068 except that
2068 does not have 3.4 mg/L silver nitrate. The third medium (2067)
was added at regular intervals (treatment 2) or the spent medium
was removed and fresh medium was added (treatment 3). The
replacement or dilution of 2202 with 2067 is likely to enhance
regeneration. The size range of the plants produced by this method
was adequate for transplanting to a plug and had a survival rate of
almost 100%. Copy number analysis of nearly 170 events using
Taqman.RTM. assay on the 3' region of the pin II transcription
termination sequence gene present in the expression unit of the DNA
construct used for transformation revealed that about 78% of the
plants contained 1-2 copy, indicating production of higher
percentage of usable plants as compared to only about 60% of plants
with 1-2 copies as typically obtained with the current method. Only
three plants from the experiment had zero copy indicating very few
escapes. Transgenic plants could also be produced for transplanting
within as little as 4 weeks as shown in FIG. 3A.
TABLE-US-00009 TABLE 9 Production of transgenic plants using a new
regeneration and elongation medium. % TF is the mean of at least 2
independent experiments and is based on % of independent transgenic
plant events. STEPS Treatment 1 Treatment 2 Treatment 3 Co-culture
and Delay; Lynx 1947 Lynx 1947 Lynx 1947 1 wk (7-10 days) 1st
transfer; 1 wk Lynx 2202 Lynx 2202 Lynx 2202 2nd transfer, 1 wk
Lynx 2068 Lynx 2067 Lynx 2067 3rd transfer, 1 wk Lynx 2067 Lynx
2067 Lynx 2067 4th transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 5th
transfer, 1 wk Lynx 2067 Lynx 2067 Lynx 2067 6th transfer Plug Plug
Plug TF 27.1 33.8 40.6
Example 9
[0070] Alternative Two and Three Step Protocols
[0071] This example illustrates production of transgenic plants by
further reducing the number of transfer steps and/or
aspiration/addition of media steps and/or media as shown in FIG. 4
and in Tables 10 and 11. One important component of the present
method is a short callus phase while speeding-up the regeneration
at the same time. In this approach, following co-culture/delay
(1.sup.st medium), tissues were transferred to a regeneration
medium (2.sup.nd medium; e.g. 2202) for a week to speed-up the
regeneration process (Table 10). However, such a step could
interfere with easy automation of this method as this 2.sup.nd
medium, comprising auxin which delays elongation, would need to be
removed prior to adding the 3.sup.rd medium (e.g. growth and
elongation medium 2067). This issue was overcome by identifying a
different second medium without any auxin but some cytokinin (e.g.
2347, 2348, 2415, 2414) as the regeneration medium which can
support regeneration, elongation and growth in place of the 2nd
medium (i.e. 2202), thereby removing the need to aspirate off the
medium. In treatments 2, 3, 4, and 5 after the first transfer,
growth regulator free 2067 was added to the containers. The
2.sup.nd medium used in treatment 5 is a modified version of Lynx
2067 as it contains small amount of BAP and may be used for
regeneration and elongation as it does not contain any auxin (e.g.
2347) as shown with the success of treatment 5. Thus, as shown in
FIG. 4, bottom, a rapid and simple plant transformation protocol
displaying excellent TF, and consisting of only two media steps, is
achieved. Furthermore, the ability to simply add medium without
aspirating off the old medium makes the system amenable for
automation.
TABLE-US-00010 TABLE 10 Production of transgenic plants in three
culture steps. # plants Total # to Events Expt # Treatment
selection Produced % TF 8205-1 8 wks-Liquid 110 46 41.8 8205-2 6
wks-Liquid 100 38 38.0 8205-3 6 weeks-liquid with 48 20 41.7
transformation in three steps
[0072] As shown in Table 11, transformation was achieved across all
the treatments, indicating that elimination of auxin containing
medium (2202) is possible without affecting TF. Additionally,
transformation using regeneration and elongation medium comprising
no auxin and some cytokinin following the co-culture/delay was
possible as shown with 2347, 2348, 2414, and 2415 contain
glyphosate at the concentration shown in parentheses.
TABLE-US-00011 TABLE 11 Experimental design for Testing Production
of Transgenic Plants in Two Steps. For media compositions see
Tables 2 and 3. STEPS Treatment 1 Treatment 2 Treatment 3 Treatment
4 Treament 5 Co-culture and Delay; Lynx 1947 10 days 1st transfer;
1 wk, 2202 2348 2415 2414 1347 dark 30 C. (0.2 mM) (0.1 mM) (0.02
mM) (0.1 mM) 2nd transfer; 1 wk, Lynx 2067 dark 30 C. 4th transfer;
3 wks, Lynx 2067 light 27 C. 5th transfer Plug TF .+-. SD 48.9 .+-.
9.5 46.5 .+-. 9.7 39.5 .+-. 12.5 40.5 .+-. 7.5 42.5 .+-. 9.7
Example 10
[0073] Transformation of Recalcitrant Corn Genotypes
[0074] This example illustrates production of transgenic plants
using a recipient elite corn variety which was found to possess a
poor embryogenic culture response (i.e. is considered
"recalcitrant") relative to a control elite genotype commonly used
for transformation via method comprising a separate step of callus
formation during selection as described by Cai et al. Only one
transgenic event was obtained from 6 experiments utilizing about
1172 explants with the control line, whereas two studies utilizing
the rapid transformation methods of the present invention resulted
in TF's of about 16.9% and 19.5%, indicating that these methods can
be successfully applied to recalcitrant lines. In Table 12, % TF is
the mean of 4 independent experiments and is based on % of
independent transgenic plant events. In some experiments a TF of
about 30-40% could be obtained.
TABLE-US-00012 TABLE 12 Modified RLC to facilitate production of
plants of an elite line in about 6 weeks. STEPS Treatment 3
Treatment 4 Co-culture and delay Lynx 1947 Lynx 1947 2nd Transfer
dark Lynx 2063 (callus Lynx 2202 30.degree. C.) proliferation and
selection) (regeneration) 3rd Transfer (dark Lynx 2063 (callus Lynx
2202 30.degree. C.) proliferation and selection) (regeneration) 4th
Transfer (dark Lynx 2068 Lynx 2068 30.degree. C.) (regeneration)
(regeneration) 5th Transfer (light Lynx 2067 (elongation Lynx 2067
(elongation 27.degree. C.) and growth) and growth) 6th Transfer
light Lynx 2067 (elongation Lynx 2067 (elongation 27.degree. C.)
and growth) and growth) To Plug To Plug To Plug TF % 16.9 19.5
Example 11
[0075] Methods for Evaluating Transformability of Corn Lines
[0076] This example illustrates rapid identification of genotypes
for transformation competence in a few simple steps. In this
method, explants are cultured on a medium capable of producing
shoot primordia in a short time (medium such as 1947; Table 2). One
week post culture, the explants are transferred to a
regeneration/elongation medium (e.g. Lynx 2424; Table 13) for 2-3
weeks at 30.degree. C. in dark conditions. Lines producing
plantlets can be transferred to a growth medium (e.g. Lynx 2427;
Table 13) for a period of 2-3 wks. Lines capable of producing
and/or regenerating shoot buds through this screening approach will
be amenable to a rapid transformation procedure such as outlined
above, without the need for a separate callus formation step during
their culture.
TABLE-US-00013 TABLE 13 Media Used for Evaluating Transformability
of Corn Lines Media Components/L (Suppliers) 2424 2427 MS Basal
Salts (Phytotech) 4.33 g 4.33 g MS Vitamins (100X) (Phytotech) 10
mL 10 mL Thiamine HCL (Sigma) 0.5 mg 0 Sucrose (Phytotech) 50 g 60
g Proline (Sigma) 1.38 0 Casamino Acids (Diko) 0.5 g 0 Adjust pH to
5.8 5.8 Phytagar (Gibco) 6 5.5 g Post autoclave additives BAP
(Sigma) 0.01 mg/l 0
Example 12
[0077] Reduced Product Development Cycle Time via Rapid
Transformation
[0078] The invention also provides an expanded priority development
window for transgenic plant product development. Such product
development is a lengthy process--it can take a minimum of 7-8
years to proceed from an idea and a gene to a commercial product in
the form of hybrid corn seed sold to growers. The field of plant
biotechnology, and specifically transgenic corn product
development, is highly competitive and removing one or more years
from a product development cycle can give a company huge returns in
market share and revenue.
[0079] Using a plant (e.g. corn) transformation protocol that takes
about 11-12 weeks to produce transformed plants, the development
window typically extends from late November to early January.
Subsequent to collection and analysis of Midwest U.S. yield data in
any given year, the window of time remaining after data collection
to initiate new transformations based on that data, while being
able to yield test resulting transformants as hybrids in the second
subsequent Midwest growing season is limited to no later than early
January, due to the subsequent activities outlined in FIG. 5. These
activities include cultivating R0 generation plant and performing
event characterization, completion of R0 plant development
including pollination and seed preparation, R1 plant development
including identification of homozygotes and collection of seed, and
finally cultivation of another generation to create hybrids and to
distribute seed to field testing locations.
[0080] An acceleration of transgenic corn product development is
achieved by shortening the time required for corn transformation
(time from DNA introduction into cells until plants to soil) such
that one full calendar year is removed from the product development
cycle of the corn product development pipeline. This is
accomplished by shortening the corn transformation protocol from
11-12 weeks or more, to 6-7 weeks or less as shown in blue in FIG.
5. This expands the "priority development window", which is defined
as the time from when Midwest U.S. yield data is available in any
given growing season until the last possible date at which a
transformation can be initiated and transformed lines resulting
from these transformations can be yield tested in the U.S. as
hybrids, in the second sequential U.S. growing season subsequent to
the time of transformation. Yield data generated in the Midwest is
critical to U.S. product development regardless of the product.
Using a 6-7 week transformation protocol expands the priority
development window by 5-6 weeks (FIG. 5), allowing for more time to
make business critical decisions or up to twice the transformation
capacity with no increase in transformation resources in a
timeframe such that yield testing of transformants initiated in the
priority development window is possible in the second subsequent
growing season (FIG. 5) instead of waiting for a full calendar year
before yield testing these transformants.
[0081] All of the compositions and methods disclosed and claimed
herein can be made and executed without undue experimentation in
light of the present disclosure. While the compositions and methods
of this invention have been described in terms of the foregoing
illustrative embodiments, it will be apparent to those of skill in
the art that variations, changes, modifications, and alterations
may be applied to the composition, methods, and in the steps or in
the sequence of steps of the methods described herein, without
departing from the true concept, spirit, and scope of the
invention. More specifically, it will be apparent that certain
agents that are both chemically and physiologically related may be
substituted for the agents described herein while the same or
similar results would be achieved. All such similar substitutes and
modifications apparent to those skilled in the art are deemed to be
within the spirit, scope, and concept of the invention as defined
by the appended claims.
REFERENCES
[0082] The following references, to the extent they provide
exemplary procedural or other details supplementary to those set
forth herein, are specifically incorporated herein by reference:
[0083] U.S. Pat. Nos. 4,769,061, 4,757,011, 4,971,908, 4,940,835,
4,971,908, 5,352,605, 5,641,876, 6,294,714, and 7,150,993 [0084]
U.S. Patent Application Publn. 2004/0244075; US Patent Application
Publn. 2005/0246786 [0085] U.S. patent application Ser. No.
11/749,583 [0086] Broothaerts et al., Nature, 433:629-633, 2005.
[0087] Chu et al., Scientia Sinica, 18:659-668, 1975. [0088] Duncan
et al., Planta, 165:322-332, 1985. [0089] Frame et al., Plant
Physiol., 129:13-22, 2002. [0090] Frame et al., Plant Cell Rep.,
25:1024-1034, 2006. [0091] Gamborg et al., Exp. Cell Res.,
50:151-158: 1968. [0092] Ishida et al., Nature Biotech.,
14:745-750, 1996. [0093] Linsmaier and Skoog, Physiol. Plant., 18
100, 1965. [0094] Matthys-Rochon et al., J. Exp. Bot., 49:839-845,
1998. [0095] McCown and Lloyd, HortScience, 16:453, 1981. [0096]
Miki and McHugh, J. Biotechnol., 107:193-232, 2004. [0097]
Murashige and Skoog, Physiol. Plant, 15:473-497, 1962. [0098]
Nitsch and Nitsch, Science, 163:85-87,1969. [0099] Sambrook et al.,
In: Molecular cloning, Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, N.Y., 2000. [0100] Schenk and Hildebrandt, Can. J.
Bot., 50: 199-204, 1972. [0101] Toki et al. Plant J. 47:969-978,
2006. [0102] Uchimiya and Murashige, Plant Physiol. 15:73, 1962.
[0103] Zhao et al., Molec. Breeding, 8:323-333, 2001.
* * * * *